Skip to main content

Advertisement

Log in

HIV Neuropathy—a Review of Mechanisms, Diagnosis, and Treatment of Pain

  • Neuropathic Pain (A Abd-Elsayed, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This article is a systematic review of data from 2018 to 2020 regarding information from publications on epidemiologic, diagnostic, and therapeutic advancements in human immunodeficiency virus–associated peripheral neuropathy.

Recent Findings

The epidemiology/pathology of HIV neuropathy is discussed. Diagnostics includes skin wrinkling-eutectic mixture of local anesthetic test and neurologic examinations. Therapeutic interventions include pharmacologic and nonpharmacologic management as well as self-management strategies.

Summary

Peripheral neuropathy continues to affect the lives of persons living with HIV. First-line treatment with pregabalin or gabapentin for HIV neuropathic pain has limited data on adequate response. Exercise and self-management strategies may provide benefit in pain reduction. Continuing research on risk factors and biomarkers for HIV-related peripheral neuropathy will be critical for future diagnostic and therapeutic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. HIV/AIDS. World Health Organization. Published 2020. https://www.who.int/health-topics/hiv-aids/

  2. Evans SR, Ellis RJ, Chen H, Yeh TM, Lee AJ, Schifitto G, et al. Peripheral neuropathy in HIV : prevalence and risk factors. Aids. 2011;25(7):919–28. https://doi.org/10.1097/QAD.0b013e328345889d.Peripheral.

    Article  PubMed  Google Scholar 

  3. Centner CM, Bateman KJ, Heckmann JM. Manifestations of HIV infection in the peripheral nervous system. Lancet Neurol. 2013;12(3):295–309. https://doi.org/10.1016/S1474-4422(13)70002-4.

    Article  PubMed  Google Scholar 

  4. Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs. 2000;59(6):1251–60. https://doi.org/10.2165/00003495-200059060-00005.

    Article  CAS  PubMed  Google Scholar 

  5. Asahchop EL, Branton WG, Krishnan A, et al. HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction. JCI insight. 2018. https://doi.org/10.1172/jci.insight.122450.

  6. Bokore A, Korme B, Bayisa G. Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, west Ethiopia: a cross-sectional study. BMC Pharmacol Toxicol. 2018;19(1):1–8. https://doi.org/10.1186/s40360-018-0220-7.

    Article  CAS  Google Scholar 

  7. Erlandson KM, Zhang L, Ng DK, Althoff KN, Palella FJ, Kingsley LA, et al. Risk factors for falls, falls with injury, and falls with fracture among older men with or at risk of HIV infection. J Acquir Immune Defic Syndr. 2019;81(4):E117–26. https://doi.org/10.1097/QAI.0000000000002074.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hagos L, Fessehaye S, Anand IS. Nature and prevalence of adverse drug reaction of antiretroviral medications in Halibet National Referral Hospital: a retrospective study. BMC Pharmacol Toxicol. 2019;20(1):1–7. https://doi.org/10.1186/s40360-019-0307-9.

    Article  Google Scholar 

  9. Moketla MB, Wadley AL, Kamerman P, De Assis Rosa D. Pharmacogenetic variation influences sensory neuropathy occurrence in Southern Africans treated with stavudine-containing antiretroviral therapy. PLoS One. 2018;13(10):1–11. https://doi.org/10.1371/journal.pone.0204111.

    Article  CAS  Google Scholar 

  10. Sakabumi DZ, Moore RC, Tang B, et al. Chronic distal sensory polyneuropathy is a major contributor to balance disturbances in persons living with HIV. JAIDS J Acquir Immune Defic Syndr. 2019;82(2):e43. https://doi.org/10.1097/qai.0000000000002115.

    Article  Google Scholar 

  11. Schnall R, Jia H, Reame N. Association between HIV symptom burden and inflammatory cytokines: an analysis by sex and menopause stage. J Women's Health. 2020;29(1):119–27. https://doi.org/10.1089/jwh.2019.7749.

    Article  Google Scholar 

  12. Schnall R, Siegel K, Jia H, Olender S, Hirshfield S. Racial and socioeceonomic disparities in the symptom profile of persons living with HIV. AIDS Care. 2018;30(6):774–83. https://doi.org/10.1080/09540121.2017.1417532.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Gonzalez-Duarte A, Robinson-Papp J, Simpson DM. Diagnosis and management of HIV-associated neuropathy. Neurol Clin. 2008;26(3):821–32. https://doi.org/10.1016/j.ncl.2008.04.001.

    Article  PubMed  Google Scholar 

  14. Mawuntu AHP, Mahama CN, Khosama H, Estiasari R, Imran D. Early detection of peripheral neuropathy using stimulated skin wrinkling test in human immunodeficiency virus infected patients: a cross-sectional study. Med (United States). 2018. https://doi.org/10.1097/MD.0000000000011526.

  15. Gewandter JS, Gibbons CH, Campagnolo M, Lee J, Chaudari J, Ward N, et al. Clinician-rated measures for distal symmetrical axonal polyneuropathy: ACTTION systematic review. Neurology. 2019;93(8):346–60. https://doi.org/10.1212/WNL.0000000000007974.

    Article  PubMed  Google Scholar 

  16. Phillips TJC, Cherry CL, Cox S, Marshall SJ, Rice ASC. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS One. 2010;5(12). https://doi.org/10.1371/journal.pone.0014433.

  17. Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003;60(9):1508–14. https://doi.org/10.1212/01.WNL.0000063304.88470.D9.

    Article  CAS  PubMed  Google Scholar 

  18. Hahn K, Arendt G, Braun JS, Giesen HJ, Husstedt IW, Maschke M, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004;251(10):1260–6. https://doi.org/10.1007/s00415-004-0529-6.

    Article  CAS  PubMed  Google Scholar 

  19. Knezevic NN, Candido KD, Rana S, Knezevic I. The use of spinal cord neuromodulation in the management of HIV-related polyneuropathy. Pain Physician. 2015;18(4):E643–50.

    PubMed  Google Scholar 

  20. Newshan G. Pain management in HIV and AIDS. GMHC treat issues. 1995;9(4):5 10-2.

    CAS  PubMed  Google Scholar 

  21. Sun H, He M, Pang J, Guo X, Huo Y, Ma J. Continuous lumbar sympathetic blockade enhances the effect of lumbar sympatholysis on refractory diabetic neuropathy: a randomized controlled trial. Diabetes Ther. 2020;11(11):2647–55. https://doi.org/10.1007/s13300-020-00918-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Simpson DM, Schifitto G, Clifford DB, Murphy TK, Durso-de Cruz E, Glue P, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology. 2010;74(5):413–20. https://doi.org/10.1212/WNL.0b013e3181ccc6ef.

    Article  CAS  PubMed Central  Google Scholar 

  23. Kieburtz K, Simpson D, Yiannoutsos C, Max MB, Hall CD, Ellis RJ, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology. 1998;51(6):1682–8 http://www.ncbi.nlm.nih.gov/pubmed/9855523.

    Article  CAS  Google Scholar 

  24. Girach A, Julian TH, Varrassi G, Paladini A, Vadalouka A, Zis P. Quality of life in painful peripheral neuropathies: a systematic review. Pain Res Manag. 2019;2019:1–9. https://doi.org/10.1155/2019/2091960.

    Article  Google Scholar 

  25. Derry S, Bell RF, Straube S, Wiffen PJ, Aldington D, Moore RA. Pregabalin for neuropathic pain in adults. Cochrane Database Syst Rev. 2019;2019(1). https://doi.org/10.1002/14651858.CD007076.pub3.

  26. Amaniti A, Sardeli C, Fyntanidou V, Papakonstantinou P, Dalakakis I, Mylonas A, et al. Pharmacologic and non-pharmacologic interventions for hiv-neuropathy pain. A systematic review and a meta-analysis. Med. 2019;55. https://doi.org/10.3390/medicina55120762.

  27. Maharaj SS, Yakasai AM. Does a rehabilitation program of aerobic and progressive resisted exercises influence HIV-induced distal neuropathic pain? Am J Phys Med Rehabil. 2018;97:364–9. https://doi.org/10.1097/PHM.0000000000000866.

    Article  PubMed  Google Scholar 

  28. Schnall R, Cho H, Mangone A, Pichon A, Jia H. Mobile health technology for improving symptom management in low income persons living with HIV. AIDS Behav. 2018;22(10):3373–83. https://doi.org/10.1007/s10461-017-2014-0.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kaitlyn E. Egan.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Neuropathic Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Egan, K.E., Caldwell, G.M. & Eckmann, M.S. HIV Neuropathy—a Review of Mechanisms, Diagnosis, and Treatment of Pain. Curr Pain Headache Rep 25, 55 (2021). https://doi.org/10.1007/s11916-021-00971-2

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11916-021-00971-2

Keywords

Navigation